Approximately 95% of SMA patients have homozygous deletions in SMN1, and the remaining ∼5% are hemizygous for the deletion over a missense mutation in SMN1 (Burghes and Beattie 2009). This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.